Elliot K. Fishman, MD, professor of radiology, surgery, oncology and urology at Johns Hopkins Hospital seeks the help of GPU-accelerated deep learning artificial intelligence to detect pancreatic cancer early which is nearly impossible for humans alone.
The most prevalent type of kidney cancer, clear cell kidney cancer, could be predicted years prior to clinical diagnosis by a crucial biomarker of kidney disease.
Findings from a study conducted by Prof. Marco Falasca from Queen Mary University of London (QMUL) in the United Kingdom and team on a mouse model of pancreatic cancer, which they injected with cannabidiol (CBD), naturally occurring cannabis along with a classic chemotherapy drug, Gemcitabine, revealed that the rodents lived almost three times more than mice from a control group, which had been treated with Gemcitabine only.
A European Radiology Experimental journal article describes how a team of researchers have established and validated an augmented reality system that could enable high accuracy interventional cancer treatments.
Research in prostate cancer could speed up drastically with a new breakthrough in prostate cancer cells grown in-vitro which could transform future drug trials.
Silencing an earlier known protein could hamper tumor development and increase the efficacy of immunotherapy treatments, researchers discovered at the Bloomberg~Kimmel Institute for Cancer Immunotherapy in the Johns Hopkins Kimmel Cancer Center.
$7.6 million has been granted to SkinVision, an Amsterdam-based skin cancer screening app, as backing from active investors Leo Pharma and PHS Fund, with supplementary aid from unnamed new sponsors which the company called "high net worth impact investors."
Based on studies that have revealed how specific malignancies thrive on cholesterol, and that raised serum cholesterol levels are linked to the risk of cancer and a drug compound called leelamine that has shown to retard tumor-growth in melanoma...
Endomag received premarket approval from the FDA for Magtrace, the novel non-radioactive dual-tracer for lymphatic plotting in breast cancer patients which facilitates the implementation of magnetic detection during sentinel lymph node biopsy procedures to spot sentinel lymph nodes for surgical excision.
Lawson Health Research Institute, Memorial Sloan Kettering Cancer Center, the Royal Marsden and Epic Sciences conducted an international mutual study which discovered a novel blood test that can foresee advanced prostate cancer patient response to particular treatments, resulting in better survival.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.